Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study

Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump Placement

(2020) Brian C. Brajcich et al.   ANNALS OF SURGICAL ONCOLOGY

Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial

(2019) F. E. Buisman et al.   BMC CANCER

Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands

(2019) Florian E. Buisman et al.   ANNALS OF SURGICAL ONCOLOGY

Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma

(2019) Andrea Cercek et al.   JAMA Oncology

Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential

(2017) Linda M. Pak et al.   JOURNAL OF SURGICAL ONCOLOGY

Hepatic Artery Infusional Chemotherapy

(2016) Heather L. Lewis et al.   SURGICAL CLINICS OF NORTH AMERICA

Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer

(2015) Michael I. DʼAngelica et al.   ANNALS OF SURGERY

Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era

(2014) Y.J. Ko et al.   Current Oncology

Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement

(2014) P.J. Karanicolas et al.   Current Oncology

Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer

(2013) M. Peeters et al.   ANNALS OF ONCOLOGY

Biliary Sclerosis after Hepatic Arterial Infusion Pump Chemotherapy for Patients with Colorectal Cancer Liver Metastasis: Incidence, Clinical Features, and Risk Factors

(2011) Kaori Ito et al.   ANNALS OF SURGICAL ONCOLOGY

Palliative excisional surgery for primary colorectal cancer in patients with incurable metastatic disease. Is there a survival benefit? A systematic review

(2011) S. Anwar et al.   Colorectal Disease

Regional Hepatic Chemotherapies in Treatment of Colorectal Cancer Metastases to the Liver

(2010) John B. Ammori et al.   SEMINARS IN ONCOLOGY

Meta-Analysis of Survival of Patients with Stage IV Colorectal Cancer Managed with Surgical Resection Versus Chemotherapy Alone

(2010) A. P. Stillwell et al.   WORLD JOURNAL OF SURGERY

Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma

(2009) Nancy E. Kemeny et al.   JOURNAL OF CLINICAL ONCOLOGY

The role of floxuridine in metastatic liver disease

(2009) D. G. Power et al.   MOLECULAR CANCER THERAPEUTICS

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review

(2008) Andrew Eisenberger et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741

(2008) Hanna K. Sanoff et al.   JOURNAL OF CLINICAL ONCOLOGY